IBDEI1YB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32664,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32664,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,32664,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,32665,0)
 ;;=90834^^144^1558^2^^^^1
 ;;^UTILITY(U,$J,358.3,32665,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32665,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,32665,1,3,0)
 ;;=3^Psychotherapy 38-52 min
 ;;^UTILITY(U,$J,358.3,32666,0)
 ;;=90837^^144^1558^3^^^^1
 ;;^UTILITY(U,$J,358.3,32666,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32666,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,32666,1,3,0)
 ;;=3^Psychotherapy 53-89 min
 ;;^UTILITY(U,$J,358.3,32667,0)
 ;;=J1631^^144^1559^6^^^^1
 ;;^UTILITY(U,$J,358.3,32667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32667,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,32667,1,3,0)
 ;;=3^Haloperidol Decanoate,per 50 mg
 ;;^UTILITY(U,$J,358.3,32668,0)
 ;;=97545^^144^1559^29^^^^1
 ;;^UTILITY(U,$J,358.3,32668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32668,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,32668,1,3,0)
 ;;=3^Work Hardening/Condition,Init 2 hrs
 ;;^UTILITY(U,$J,358.3,32669,0)
 ;;=97546^^144^1559^30^^^^1
 ;;^UTILITY(U,$J,358.3,32669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32669,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,32669,1,3,0)
 ;;=3^Work Hardening/Conditioning,ea addl hr
 ;;^UTILITY(U,$J,358.3,32670,0)
 ;;=97537^^144^1559^3^^^^1
 ;;^UTILITY(U,$J,358.3,32670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32670,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,32670,1,3,0)
 ;;=3^Community/Work Reintegration per 15 min
 ;;^UTILITY(U,$J,358.3,32671,0)
 ;;=97532^^144^1559^2^^^^1
 ;;^UTILITY(U,$J,358.3,32671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32671,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,32671,1,3,0)
 ;;=3^Cognitive Skills Development,ea 15 min
 ;;^UTILITY(U,$J,358.3,32672,0)
 ;;=97533^^144^1559^20^^^^1
 ;;^UTILITY(U,$J,358.3,32672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32672,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,32672,1,3,0)
 ;;=3^Sensory Integrative Techniques,per 15 min
 ;;^UTILITY(U,$J,358.3,32673,0)
 ;;=H0004^^144^1559^8^^^^1
 ;;^UTILITY(U,$J,358.3,32673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32673,1,2,0)
 ;;=2^H0004
 ;;^UTILITY(U,$J,358.3,32673,1,3,0)
 ;;=3^Ind Counseling & Therapy, per 15 min
 ;;^UTILITY(U,$J,358.3,32674,0)
 ;;=H0046^^144^1559^13^^^^1
 ;;^UTILITY(U,$J,358.3,32674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32674,1,2,0)
 ;;=2^H0046
 ;;^UTILITY(U,$J,358.3,32674,1,3,0)
 ;;=3^PTSD Group
 ;;^UTILITY(U,$J,358.3,32675,0)
 ;;=96119^^144^1559^10^^^^1
 ;;^UTILITY(U,$J,358.3,32675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32675,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,32675,1,3,0)
 ;;=3^Neuropsych Test by tech,per hr
 ;;^UTILITY(U,$J,358.3,32676,0)
 ;;=96402^^144^1559^9^^^^1
 ;;^UTILITY(U,$J,358.3,32676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32676,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,32676,1,3,0)
 ;;=3^Injec,IM,anti-neplastic hormonal anti-neoplastic drug
 ;;^UTILITY(U,$J,358.3,32677,0)
 ;;=96102^^144^1559^15^^^^1
 ;;^UTILITY(U,$J,358.3,32677,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32677,1,2,0)
 ;;=2^96102
 ;;^UTILITY(U,$J,358.3,32677,1,3,0)
 ;;=3^Psych Test by Tech,per hr
 ;;^UTILITY(U,$J,358.3,32678,0)
 ;;=96103^^144^1559^16^^^^1
 ;;^UTILITY(U,$J,358.3,32678,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32678,1,2,0)
 ;;=2^96103
 ;;^UTILITY(U,$J,358.3,32678,1,3,0)
 ;;=3^Psych Test by computer
 ;;^UTILITY(U,$J,358.3,32679,0)
 ;;=96120^^144^1559^11^^^^1
 ;;^UTILITY(U,$J,358.3,32679,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32679,1,2,0)
 ;;=2^96120
